Skip to main content
. 2016 Aug 4;7(36):58696–58708. doi: 10.18632/oncotarget.11061

Figure 2. Triage of clinical specimens to different laboratories in the integrated approach to patient-oriented molecular and histomorphologic diagnosis for targeted real time management.

Figure 2

HHS Vulnerability Disclosure